Updated Jul 16, 2026
MCANDREW STEPHEN J is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Stephen J. McAndrew is the Chief Business Officer at Sonnet BioTherapeutics Holdings, Inc. He has been involved in multiple SEC filings related to his role in the company, although there is limited public information available about his career outside of this position.
| Role | Chief Business Officer |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2025-12-04 | SONN | Sonnet BioTherapeutics Holdings, Inc. | D — Derivative transaction | 6.4K | — | |
| 2025-07-11 | SONN | Sonnet BioTherapeutics Holdings, Inc. | A — Grant or award | 6.0K | — |
Stephen J. McAndrew is the Chief Business Officer at Sonnet BioTherapeutics Holdings, Inc. He has been involved in multiple SEC filings related to his role in the company, although there is limited public information available about his career outside of this position.…
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live MCANDREW STEPHEN J profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.